Presage Feasibility Questionnaire

Presage Feasibility Questionnaire

This form is useful for any healthcare company or institutions that wants to evaluate the presage feasibility of certain clinic areas for safety and quality. Form Preview
Clone of Presage Feasibility Questionnaire
  • Site Feasibility Questionnaire

  • Presage Biosciences, Inc. is currently evaluating clinical sites for two separate upcoming Phase I/II clinical trials with our clinical stage CDK inhibitor, voruciclib, in combination with other oral treatments. Participation in both studies is not required.



    Clinical Study BCL-1601

    A Phase I/II study of voruciclib as a single agent and in combination with venetoclax in patients with relapsed/refractory diffuse large B-cell lymphoma.

    Click to download BCL-1601 DLBCL Synopsis


     

    Clinical Study TNB-1701

    TNB-1701: A Phase 1/2 study of voruciclib and ixazomib as single agents and in combination in patients with advanced solid malignancies and unresectable or metastatic triple negative breast cancer.

    Click to download TNB-1601 TNBC Synopsis

     

    If you have questions please contact clinops@presagebio.com

     

  •  -
Now create your own JotForm - It's free! Create your own JotForm